Gujarat's Holistic Healthcare Summit Sets Stage for Vibrant Gujarat Global Summit
Gujarat has established a comprehensive healthcare ecosystem, spanning government, private, corporate, and public-private partnership (PPP) models.
Union Health Minister Inaugurates Multiple Healthcare Facilities in New Delhi
The Union Health Minister highlighted the changing dynamics of the health sector in India.
Cipla Announces JV in US with Kemwell Biopharma and Manipal Education & Medical Group
The primary goal of this joint venture is to develop and commercialise novel Cell therapy products for major unmet medical needs in the United States, Japan, and EU regions.
Uppaluri K&H Personalized Medicine Clinic Unveil AI platform - GeneConnectRx
Uppaluri K&H Personalized Medicine Clinic Pvt Ltd., unveiled GeneConnectRx, an innovative AI platform from GenepoweRx, the diagnostic wing of the group.
MOMA Therapeutics and Roche Announce Five-Year Discovery Collaboration
This partnership provides Roche with access to MOMA’s proprietary KnowledgeBase platform for the identification and prosecution of a certain number of novel drug targets involved in promoting cancer cell growth and survival.
Novartis Set to Acquire Calypso in Transformative Agreement
Calypso, a spin-out from Merck, is focused on the research and development of monoclonal antibodies for an array of autoimmune indications, with an expertise in IL-15 biology.
India's Ministry of Health Revises Pharmaceutical Manufacturing Rules
The move is seen as a step towards aligning with international quality standards and ensuring the production of safe and high-quality drugs.
Union Health Minister Inaugurates CDSCO Sub Zonal Office and Central Drug Testing Laboratory in MP
Dr. Mansukh Mandaviya, Union Minister of Health and Family Welfare inaugurated the Central Drugs Standard Control Organization (CDSCO) Sub Zonal office and Central Drug Testing Laboratory (CDTL) in Indore, Madhya Pradesh.
Dr Reddy's Recalls 8,000 Bottles of Generic Drug in US Over Packaging Error
The Hyderabad-based drug major is recalling 8,280 bottles of Tacrolimus capsules from the US market for "presence of foreign tablets/capsules" in the affected lot.
Supriya Lifesciences Receives GMP Certification from ANVISA Brazil
Supriya Lifescience Limited has announced that its manufacturing site in Lote Parshuram has received Good Manufacturing Practice (GMP) certification from the Regulatory Authority of Brazil, ANVISA.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy